SuperworthMangoceuticals shares outstanding MGRX
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 17.1M
- On a year earlier
- +71.5%
- more shares
Mangoceuticals had 17.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 71.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 14.1M | +441% |
| FY2024 | 2.6M | +100% |
| FY2023 | 1.3M | +46% |
| FY2022 | 894.9K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 17.1M | +71% | |
| Q1 FY26 | 16.5M | +259% | |
| Q4 FY25 | 14.1M | +441% | |
| Q3 FY25 | 11.5M | +472% | |
| Q2 FY25 | 10M | +474% | |
| Q1 FY25 | 4.6M | +192% | |
| Q4 FY24 | 2.6M | +100% | |
| Q3 FY24 | 2M | +90% | |
| Q2 FY24 | 1.7M | +65% | |
| Q1 FY24 | 1.6M | +110% | |
| Q4 FY23 | 1.3M | +46% | |
| Q3 FY23 | 1.1M | +58% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Mangoceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.